Cargando…

Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma

Synaptojanin 2 (SYNJ2) regulates cell proliferation and apoptosis via dephosphorylating plasma membrane phosphoinositides. Aim of this study is to first seek the full-scale expression levels and potential emerging roles of SYNJ2 in hepatocellular carcinoma (HCC). We systematically analyzed SYNJ2 mRN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Rui, Mo, Wei-Jia, Huang, Lan-Shan, Chen, Ji-Tian, Wu, Wei-Zi, He, Wei-Ying, Feng, Zhen-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806346/ https://www.ncbi.nlm.nih.gov/pubmed/33641617 http://dx.doi.org/10.1080/21655979.2021.1890399

Ejemplares similares

Mutations in Synaptojanin Disrupt Synaptic Vesicle Recycling
por: Harris, Todd W., et al.
Publicado: (2000)

synaptojanin1 Is Required for Temporal Fidelity of Synaptic Transmission in Hair Cells
por: Trapani, Josef G., et al.
Publicado: (2009)

Regulation of synaptojanin 2 5′-phosphatase activity by Src
por: Chuang, Yayu, et al.
Publicado: (2012)

Synaptojanin cooperates in vivo with endophilin through an unexpected mechanism
por: Dong, Yongming, et al.
Publicado: (2015)

Mini-review: Synaptojanin 1 and its implications in membrane trafficking
por: Choudhry, Hassaam, et al.
Publicado: (2021)

Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes
por: Pan, Ping-Yue, et al.
Publicado: (2021)

Temporal Vestibular Deficits in synaptojanin 1 (synj1) Mutants
por: Gao, Yan, et al.
Publicado: (2021)

Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase
por: Chen, Chun-Kan, et al.
Publicado: (2014)

Synaptojanin1 Modifies Endolysosomal Parameters in Cultured Ventral Midbrain Neurons
por: Zhu, Xinyu, et al.
Publicado: (2023)

Synaptojanin 1 Mutation in Parkinson's Disease Brings Further Insight into the Neuropathological Mechanisms
por: Drouet, Valérie, et al.
Publicado: (2014)

Synaptojanin2 Mutation Causes Progressive High-frequency Hearing Loss in Mice
por: Martelletti, Elisa, et al.
Publicado: (2020)

Minibrain kinase and calcineurin coordinate activity-dependent bulk endocytosis through synaptojanin
por: Peng, Yi-Jheng, et al.
Publicado: (2021)

Synaptojanin 1 Is Required for Endolysosomal Trafficking of Synaptic Proteins in Cone Photoreceptor Inner Segments
por: George, Ashley A., et al.
Publicado: (2014)

Calcineurin regulates the yeast synaptojanin Inp53/Sjl3 during membrane stress
por: Guiney, Evan L., et al.
Publicado: (2015)

A Mutation in Synaptojanin 2 Causes Progressive Hearing Loss in the ENU-Mutagenised Mouse Strain Mozart
por: Manji, Shehnaaz S. M., et al.
Publicado: (2011)

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 1
por: Cao, Mian, et al.
Publicado: (2020)

A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
por: Paesmans, Jone, et al.
Publicado: (2020)

Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology
por: Ng, Xin Yi, et al.
Publicado: (2023)

Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
por: Rafiq, Nisha Mohd, et al.
Publicado: (2023)

Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease
por: Miranda, Andre M., et al.
Publicado: (2018)

The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease
por: Ando, Kunie, et al.
Publicado: (2020)

Synaptojanin 1 Modulates Functional Recovery After Incomplete Spinal Cord Injury in Male Apolipoprotein E Epsilon 4 Mice
por: Toro, Carlos A., et al.
Publicado: (2023)

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
por: Shi, Yi, et al.
Publicado: (2021)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

SAT-313 Synaptojanin 2 Binding Protein Is Required for Efficient Somatostatin Receptor 2A Phosphorylation by G Protein Coupled Receptor Kinases and Signaling to the ERK/MAPK Pathway
por: Carr, Heather S, et al.
Publicado: (2020)

Using perturbations to identify the brain circuits underlying active vision
por: Wurtz, Robert H.
Publicado: (2015)

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma
por: Cheng, Xianyi, et al.
Publicado: (2022)

Combining data integration and molecular dynamics for target identification in α-Synuclein-aggregating neurodegenerative diseases: Structural insights on Synaptojanin-1 (Synj1)
por: Jenkins, Kirsten, et al.
Publicado: (2020)

Synaptic AP2 CCV life cycle regulation by the Eps15, ITSN1, Sgip1/AP2, synaptojanin1 interactome
por: Mishra, R., et al.
Publicado: (2021)

Perturbation Analysis of a Prognostic DDX3X-Mediated Gene Expression Signature Identifies the Antimetastatic Potential of Chaetocin in Hepatocellular Carcinoma
por: Lin, Tsung-Chieh
Publicado: (2023)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection
por: Li, Hong-Mei, et al.
Publicado: (2023)

Pathway Correlation Profile of Gene-Gene Co-Expression for Identifying Pathway Perturbation
por: Tegge, Allison N., et al.
Publicado: (2012)

Influence maximization in time bounded network identifies transcription factors regulating perturbed pathways
por: Jo, Kyuri, et al.
Publicado: (2016)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
por: He, Fei-Yan, et al.
Publicado: (2022)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma
por: Jiang, Longyang, et al.
Publicado: (2019)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpvenvh1s99gm9uli8rvkbc3rl